Biotech entity
Every one of those 1 sits in a single category, funding. Of the tracked stories, 1 of 1 also mention Chuck Schumer, the most common co-covered peer. Each carries 16 original sources on average. We currently track 1 Biotech story that mention Ebola virus outbreak, all published on June 28, 2026.
Last mentioned: Jun 28, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, funding. Of the tracked stories, 1 of 1 also mention Chuck Schumer, the most common co-covered peer. Each carries 16 original sources on average. We currently track 1 Biotech story that mention Ebola virus outbreak, all published on June 28, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 9 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Ebola virus outbreak. Shared-story counts are live from our verified record — not editorial picks.
The $1.4 billion Ebola component of the White House’s war funding request could accelerate development of new vaccines and antivirals, offering a rare bright spot for biopharma firms amid broader fiscal uncertainty.
Source: stcatharinesstandard.ca · yahoo.com
Ebola virus outbreak is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
